Varatharajalu K - Search Results

1

Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors.

Sperling G, Shatila M, Varatharajalu K, Lu Y, Altan M, Zhou Y, Zhao D, De Toni EN, Török HP, Schneider BJ, Khan A, Thomas AS, Zhang HC, Shafi MA, Wang Y. Sperling G, et al. Among authors: varatharajalu k. J Cancer Res Clin Oncol. 2023 Dec;149(19):17597-17605. doi: 10.1007/s00432-023-05461-z. Epub 2023 Nov 2. J Cancer Res Clin Oncol. 2023. PMID: 37917197

2

Colon Adenoma After Diagnosis of Immune Checkpoint Inhibitor-mediated Colitis.

Machado AP, Shatila M, De Toni EN, Török HP, Philpott J, Zhao D, Zhou Y, Varatharajalu K, Shafi MA, Zhang HC, Thomas AS, Wang Y. Machado AP, et al. Among authors: varatharajalu k. J Cancer. 2023 Aug 28;14(14):2686-2693. doi: 10.7150/jca.86635. eCollection 2023. J Cancer. 2023. PMID: 37779873 Free PMC article.

3

Electric vehicle parameter identification and state of charge estimation of Li-ion batteries: Hybrid WSO-HDLNN method.

Varatharajalu K, Manoharan M, Palanichamy TSC, Subramani S. Varatharajalu K, et al. ISA Trans. 2023 Nov;142:347-359. doi: 10.1016/j.isatra.2023.07.029. Epub 2023 Jul 25. ISA Trans. 2023. PMID: 37550119

4

Impact of Selective Immunosuppressive Therapy on Subsequent Immune-Related Adverse Events After Immune Checkpoint Inhibitor-Induced Colitis Treatment.

Pizuorno Machado A, Shatila M, Glitza Oliva IC, Altan M, Siddiqui B, Zhou Y, Varatharajalu K, Zhang HC, Thomas A, Wang Y. Pizuorno Machado A, et al. Among authors: varatharajalu k. Am J Clin Oncol. 2023 Aug 1;46(8):360-365. doi: 10.1097/COC.0000000000001016. Epub 2023 May 23. Am J Clin Oncol. 2023. PMID: 37219360

5

Obesity Measured via Body Mass Index May Be Associated with Increased Incidence but Not Worse Outcomes of Immune-Mediated Diarrhea and Colitis.

Kono M, Shatila M, Xu G, Lu Y, Mathew A, Mohajir W, Varatharajalu K, Qiao W, Thomas AS, Wang Y. Kono M, et al. Among authors: varatharajalu k. Cancers (Basel). 2023 Apr 17;15(8):2329. doi: 10.3390/cancers15082329. Cancers (Basel). 2023. PMID: 37190257 Free PMC article.

6

Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignancies.

Thomas AR, Eyada M, Kono M, Varatharajalu K, Lu Y, Xu G, Panneerselvam K, Shatila M, Altan M, Wang J, Thompson JA, Zhang HC, Khan MA, Raju GS, Thomas AS, Wang Y. Thomas AR, et al. Among authors: varatharajalu k. J Cancer Res Clin Oncol. 2023 Jul;149(8):4805-4816. doi: 10.1007/s00432-022-04405-3. Epub 2022 Oct 15. J Cancer Res Clin Oncol. 2023. PMID: 36242603

7

Mesalamine and cholestyramine for immune checkpoint inhibitor-mediated diarrhea and colitis.

Hollander B, Khurana S, Jacob JS, Altan M, Wang J, Zhao D, Varatharajalu K, Alasadi M, Thomas AS, Wang Y. Hollander B, et al. Among authors: varatharajalu k. J Cancer Res Clin Oncol. 2023 Jul;149(7):3637-3648. doi: 10.1007/s00432-022-04116-9. Epub 2022 Aug 16. J Cancer Res Clin Oncol. 2023. PMID: 35972690

8

Clostridioides difficile infection in cancer patients receiving immune checkpoint inhibitors.

Vasavada S, Panneerselvam K, Amin R, Varatharajalu K, Okhuysen PC, Oliva ICG, Wang J, Grivas P, Thomas AS, Wang Y. Vasavada S, et al. Among authors: varatharajalu k. Ann Gastroenterol. 2022 Jul-Aug;35(4):393-399. doi: 10.20524/aog.2022.0722. Epub 2022 Jun 2. Ann Gastroenterol. 2022. PMID: 35784625 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page